stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Relay Therapeutics IncRLAY
$17.853.30%0.57

Relay Therapeutics Inc (RLAY)

Date: 2026-11-03 16:00O: 17.52H: 18.01L: 17.28C: 17.85Vol: 1.112M
Schlusskurs vom Vortag:
$17.28
Offen:
$17.52
24-Stunden-Volumen:
1,115,560
Relatives Volumen:
0.50
Marktkapitalisierung:
$3.91B
Einnahmen:
$10.68M
Nettoeinkommen (Verlust:
-$272.71M
KGV:
-
EPS:
-$1.57
Netto-Cashflow:
-$213.38M
1W Leistung:
-5.25%
1M Leistung:
-5.85%
6M Leistung:
+40.33%
1Y Leistung:
+157.20%
1-Tages-Spanne:
$17.28$18.01
1-Wochen-Bereich:
$17.24$20.20
52-Wochen-Spanne:
$5.95$21.27

Relay Therapeutics Inc Aktie (RLAY) Unternehmensprofil

Firmenname
Relay Therapeutics Inc
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE, USA
Mitarbeiter
192
X
-
Nächster Verdiensttermin
2026-11-05
Neueste SEC-Einreichungen
SEC
RLAY-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Relay Therapeutics Inc Aktie (RLAY) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-07-16EingeleitetCanaccord GenuityBuy
2026-07-08EingeleitetJP MorganOverweight
2026-01-26HochstufungOppenheimerPerform → Outperform
2025-12-12HochstufungWells FargoEqual Weight → Overweight

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)15.3610.0125.551.3830.29
Operating expenses USD (M)318.09382.48398.55300.66367.73
Operating income USD (M)-302.74-372.47-373.00-299.28-364.70
Income before tax USD (M)--25.551.38-363.87
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-276.48-337.71-341.97-290.51-363.87
Basic EPS USD/shares-1.61-2.36-2.79-2.59-
Diluted EPS USD/shares-1.61-2.36-2.79-2.59-
Basic weighted shares shares (M)171.59142.87122.58112.23-
Diluted weighted shares shares (M)---112.23-

Relay Therapeutics Inc-Aktie (RLAY) Insiderhandel

  • President, R&D
    Transaktion
    Sale
    Kosten
    $18.62
    #Aktien
    2,252
    Wert ($)
    41,932
    #Aktien Gesamt
    396,878
  • Rahmer PeterOct 28 '26
    See remarks
    Transaktion
    Sale
    Kosten
    $18.62
    #Aktien
    753
    Wert ($)
    14,021
    #Aktien Gesamt
    222,904
  • Chief Financial Officer
    Transaktion
    Sale
    Kosten
    $18.62
    #Aktien
    1,469
    Wert ($)
    27,353
    #Aktien Gesamt
    103,665
  • Patel SanjivOct 07 '26
    President and CEO
    Transaktion
    Sale
    Kosten
    $18.10
    #Aktien
    48,199
    Wert ($)
    872,402
    #Aktien Gesamt
    471,301
  • SANJIV PATELOct 07 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $18.74
    #Aktien
    96,401
    Wert ($)
    1,806,555
    #Aktien Gesamt
    0
  • Officer
    Transaktion
    Proposed Sale
    Kosten
    $19.39
    #Aktien
    93,153
    Wert ($)
    1,806,237
    #Aktien Gesamt
    0
  • Chief Financial Officer
    Transaktion
    Sale
    Kosten
    $18.59
    #Aktien
    17,717
    Wert ($)
    329,322
    #Aktien Gesamt
    105,134
  • President, R&D
    Transaktion
    Sale
    Kosten
    $18.97
    #Aktien
    8,530
    Wert ($)
    161,814
    #Aktien Gesamt
    399,130
  • Patel SanjivSep 08 '26
    President and CEO
    Transaktion
    Sale
    Kosten
    $18.94
    #Aktien
    48,199
    Wert ($)
    912,889
    #Aktien Gesamt
    519,500
  • Chief Financial Officer
    Transaktion
    Sale
    Kosten
    $18.94
    #Aktien
    17,717
    Wert ($)
    335,560
    #Aktien Gesamt
    122,851
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
Bergstrom Donald APresident, R&DOct 28 '26Sale$18.622,25241,932396,878
Rahmer PeterSee remarksOct 28 '26Sale$18.6275314,021222,904
Catinazzo ThomasChief Financial OfficerOct 28 '26Sale$18.621,46927,353103,665
Patel SanjivPresident and CEOOct 07 '26Sale$18.1048,199872,402471,301
SANJIV PATELDirectorOct 07 '26Proposed Sale$18.7496,4011,806,5550
THOMAS CATINAZZOOfficerOct 06 '26Proposed Sale$19.3993,1531,806,2370
Catinazzo ThomasChief Financial OfficerOct 06 '26Sale$18.5917,717329,322105,134
Bergstrom Donald APresident, R&DSep 08 '26Sale$18.978,530161,814399,130
Patel SanjivPresident and CEOSep 08 '26Sale$18.9448,199912,889519,500
Catinazzo ThomasChief Financial OfficerSep 08 '26Sale$18.9417,717335,560122,851

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

Nov 02, 2026
Nov 02, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 30, 2026
Oct 24, 2026
Oct 24, 2026
Oct 15, 2026
Oct 15, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 07, 2026
Oct 07, 2026
Oct 06, 2026
Oct 06, 2026
Sep 23, 2026
Sep 23, 2026
Sep 21, 2026
Sep 21, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 06, 2026
Sep 06, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Aug 29, 2026
Aug 29, 2026
Aug 28, 2026
Aug 28, 2026
Aug 28, 2026
Aug 28, 2026
Aug 28, 2026
Aug 28, 2026

Ähnlich wie RLAY